Journal: Cell death & disease

Article Title: SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironment.

doi: 10.1038/s41419-023-06139-7

Figure Lengend Snippet: Fig. 7 SCF controls connective tissue-like MC accumulation in tumor lesions. A Schematic representation of anti-SCF neutralizing Ab administration in vivo. AOM/DSS-treated mice were i.p. injected three times with anti-SCF or control Ab (100 μg/mouse) starting from the fourth DSS cycle. Treated and control mice were sacrificed at 13 weeks from AOM administration. B Colon paraffin-embedded sections from AOM/DSS mice treated with Ctrl-Ig or anti-SCF neutralizing antibodies as described in (A) were stained with anti-MCP4 Ab followed by Alexa Fluor 488 secondary Abs (green). Nuclei were counterstained with DAPI (blue) and images were acquired with a Zeiss LSM980 confocal microscopy using a 20× objective. The frequencies of MCs positive for mMCP4 protease were analyzed in 20 fields randomly acquired from tumor lesions and shown as mean ± SD cells/field. Paired Student’s t test: *p < 0.05. Number of adenomas and colon lengths are shown in (C). Paired Student’s t test: *p < 0.05. Graphs are representative of two independent experiments with a total of 5 mice/group.

Article Snippet: For blocking experiments, mice were i.p. injected with anti-SCF neutralizing antibody (AB-455-NA R&D Systems) or normal goat control IgG (AB-108-C R&D Systems) (100μg/mouse) three times every 10 days starting one day before the fourth DSS cycle (see Fig. 7A).

Techniques: In Vivo, Injection, Control, Staining, Confocal Microscopy

Journal: PLoS ONE

Article Title: Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated Pathways

doi: 10.1371/journal.pone.0076822

Figure Lengend Snippet: A , KIT Y721 phosphorylation was activated by exogenous rhKITLG (100 ng/mL for 10 min following 2 h serum deprivation [ , ]) in GIST-T1 cells containing a heterozygous activating KIT mutation (n=4/group) and in GIST-T1-5R cells containing an additional, imatinib-resistant KIT mutation (n=6/group), but not in GIST882 cells lacking a WT KIT allele (n=5/group). B , Culturing with anti-human KITLG neutralizing antibody for 4 days inhibited baseline proliferation of GIST-T1 cells ( P <0.001; n=3; regression and 95% confidence band are shown as solid and dashed lines, respectively) and GIST-T1-5R cells ( P <0.001; n=6). The effect of KITLG immunoneutralization on GIST-T1 cells was blocked by preabsorbing the antibody with 10-fold molar excess of rhKITLG (see open symbols in the left panel, second row; n=3/group). KITLG immunoneutralization did not inhibit the proliferation of GIST882 or GIST48B cells lacking a WT KIT allele (note that GIST48B cells also express very low to undetectable levels of KIT protein, see ) and of LX-2 cells lacking KIT protein (n=3/cell line). C , Inhibition of the proliferation of GIST-T1 and GIST-T1-5R cells by siRNA-mediated knock-down of KITLG (n=4/cell line/group; P GIST-T1 : day 2: 0.008, days 4, 6 and 8: <0.001; P GIST-T1-5R : day 2: <0.02, day 4: 0.004, days 6 and 8: <0.001).

Article Snippet: The role of endogenous KITLG in the proliferation of GIST-T1, GIST-T1-5R, GIST882, GIST48B and LX-2 cells was tested by culturing in the above media in the presence of purified, azide-free goat polyclonal anti-human KITLG antibody (AB-255-NA, R&D Systems, Minneapolis, MN; applied for 4 days at concentrations indicated in the Results), which has been shown to neutralize KITLG-induced proliferation in the TF1 human erythroleukemic cell line [ ].

Techniques: Phospho-proteomics, Mutagenesis, Inhibition, Knockdown

Journal: PLoS ONE

Article Title: Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated Pathways

doi: 10.1371/journal.pone.0076822

Figure Lengend Snippet: Results obtained in murine and human smooth muscle cells ( A - E ), human LX-2 stellate cells ( F - G ) and human GIST-T1 cells ( H - I ) are shown. A , Hoffman modulation contrast image of primary human gastric smooth muscle cells. B , KITLG mRNA (total: soluble+membrane-bound) was readily detectable in primary human smooth muscle cells (passage 3) maintained with Smooth Muscle Growth Medium-2 containing insulin, hFGF-B, hEGF and 5% FBS (Lonza) but not in 24-h growth factor- and serum-deficient basal medium. C , Both IGF1 (100 ng/mL) and the GSK3α/β inhibitor SB415286 (30 µM) stimulated Kitl expression in murine gastric tunica muscularis organotypic cultures (n=3/group). D - E , SB415286 stimulated endogenous Kitl expression in murine primary gastric smooth muscle cells ( D ; n=3/group) and KITLG transcriptional activity in the same cell type transfected with a KITLG promoter (-2120 bp to +407 bp)-pGL3 luciferase construct ( E ; n=3/group). IGF1 (100 ng/mL; n=3/group) and SB415286 (30 µM; n=6/group) also increased endogenous KITLG mRNA expression in LX-2 ( F ) and GIST-T1 cells ( H ) and stimulated KITLG promoter activity in a time-dependent fashion (LX-2: n=6-9/group; G ; GIST-T1: n=3-11/group; I ). Groups marked by asterisk are different from the control group, and groups not sharing the same superscript letter are different from each other ( P <0.05 by post-hoc multiple comparisons).

Article Snippet: The role of endogenous KITLG in the proliferation of GIST-T1, GIST-T1-5R, GIST882, GIST48B and LX-2 cells was tested by culturing in the above media in the presence of purified, azide-free goat polyclonal anti-human KITLG antibody (AB-255-NA, R&D Systems, Minneapolis, MN; applied for 4 days at concentrations indicated in the Results), which has been shown to neutralize KITLG-induced proliferation in the TF1 human erythroleukemic cell line [ ].

Techniques: Membrane, Expressing, Activity Assay, Transfection, Luciferase, Construct, Control

Journal: PLoS ONE

Article Title: Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated Pathways

doi: 10.1371/journal.pone.0076822

Figure Lengend Snippet: A , Increased occupancy of the Kitl core promoter region by H4ac in response to 6-h rhIGF1 (100 ng/mL) and SB415286 (30 µM) treatment in murine gastric smooth muscles. Only SB415286 increased occupancy by H3K9ac ( B ). Representatives of two independent experiments, each performed in triplicates, are shown. C , Dose-dependent stimulation of KITLG expression in LX-2 cells by 24-h treatment with the class I-II HDAC inhibitor SAHA (n=3/group). D , Dose-dependent inhibition of the SB415286-induced stimulation of KITLG expression by the p300/PCAF HAT inhibitor garcinol (24 h) in LX-2 cells (n=3/group). Drugs were applied following 24-h serum deprivation. Groups marked by asterisk are different from the control group, and groups not sharing the same superscript letter are different from each other ( P <0.05 by post-hoc multiple comparisons).

Article Snippet: The role of endogenous KITLG in the proliferation of GIST-T1, GIST-T1-5R, GIST882, GIST48B and LX-2 cells was tested by culturing in the above media in the presence of purified, azide-free goat polyclonal anti-human KITLG antibody (AB-255-NA, R&D Systems, Minneapolis, MN; applied for 4 days at concentrations indicated in the Results), which has been shown to neutralize KITLG-induced proliferation in the TF1 human erythroleukemic cell line [ ].

Techniques: Muscles, Expressing, Inhibition, Control

Journal: PLoS ONE

Article Title: Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated Pathways

doi: 10.1371/journal.pone.0076822

Figure Lengend Snippet: A , Increased occupancy of the Kitl core promoter by the trithorax group-mediated, activating H3K4me2 histone modification in response to 6-h rhIGF1 (100 ng/mL) and SB415286 (30 µM) treatment in murine gastric smooth muscles. B - C , Reduced occupancy of the Kitl core promoter by the PRC2-mediated, repressive H3K27me3 histone modification ( B ) and by the PRC2 histone methyltransferase EZH2 ( C ) in response to rhIGF1 and SB415286 in the same tissues. D - F , Stimulation of KITLG expression by the indirect histone methyltransferase inhibitor Adox in murine gastric smooth muscles ( D ), LX-2 cells ( E ) and GIST-T1 cells ( F ) (n=3/group). Adox was applied for 72 h following 24-h serum deprivation. See further details in the legend to .

Article Snippet: The role of endogenous KITLG in the proliferation of GIST-T1, GIST-T1-5R, GIST882, GIST48B and LX-2 cells was tested by culturing in the above media in the presence of purified, azide-free goat polyclonal anti-human KITLG antibody (AB-255-NA, R&D Systems, Minneapolis, MN; applied for 4 days at concentrations indicated in the Results), which has been shown to neutralize KITLG-induced proliferation in the TF1 human erythroleukemic cell line [ ].

Techniques: Modification, Muscles, Expressing

Journal: PLoS ONE

Article Title: Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated Pathways

doi: 10.1371/journal.pone.0076822

Figure Lengend Snippet: A - B , Reduced occupancy of the Kitl core promoter by the repressive H3K9me2 ( A ) and H3K9me3 ( B ) histone modifications in response to 6-h rhIGF1 (100 ng/mL) and SB415286 (30 µM) treatment in murine gastric smooth muscles. C - D , Probing the role of HP1 isoforms in transcriptional repression of KITLG in LX-2 cells by siRNA- (CBX5: HP1α; 25 nM, 72 h; C ) or shRNA-mediated knock-down (CBX1: HP1β; CBX3: HP1γ; 30 µg plasmid, 72 h; D ). Note activation of KITLG expression by shRNA-mediated knock-down of HP1γ (n=3/group). E - F , Stimulation of KITLG expression by the G9A/GLP H3K9me1/2 HKMT inhibitor BIX-01294 in LX-2 cells ( E ) and GIST-T1 cells ( F ) (n=3/group). G , Stimulation of KITLG expression by the H3K9 HKMT inhibitor chaetocin in LX-2 cells (n=3/group). Drugs were applied for 24 h following 24-h serum deprivation. See further details in the legend to .

Article Snippet: The role of endogenous KITLG in the proliferation of GIST-T1, GIST-T1-5R, GIST882, GIST48B and LX-2 cells was tested by culturing in the above media in the presence of purified, azide-free goat polyclonal anti-human KITLG antibody (AB-255-NA, R&D Systems, Minneapolis, MN; applied for 4 days at concentrations indicated in the Results), which has been shown to neutralize KITLG-induced proliferation in the TF1 human erythroleukemic cell line [ ].

Techniques: Muscles, shRNA, Knockdown, Plasmid Preparation, Activation Assay, Expressing

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 1 CXCL17 is upregulated in lung metastatic breast cancer cells. a Scheme of the animal model. 4T1 cells (500,000 cells per fat pad) were implanted into the mammary fat pads and allowed to spontaneously metastasize to the lung for 24 days. Whole primary tumor in mammary or tumor nodules in the lungs (n = 3), livers (n = 4), and intestine (n = 4) and lymph nodes (tumor nodules = 7) were subjected to gene profiling. b Specific gene profile of breast cancer metastasized to lung. c The upregulation of CXCL17 protein in lung metastatic 4T1 cells. 4T1 cells were implanted into mice in an orthotic model. The expression of CXCL17 protein of 4T1 cells isolated from primary sites (mammary) or lung tissue (six pairs of 4T1 cell isolated from in mammary and lung) was assessed by ELISA after 48-h incubation. d In the left panel, the box plot generated from Kao Huang Breast GSE20685 dataset of SurvExpress showed the amount of CXCL17 expression in each group. The right panel showed the Kaplan-Meier time to metastasis curve. e The results were from Van De Vijver Nature 2002 dataset of SurvExpress. The left and right panels showed CXCL17 expression and the Kaplan-Meier time to metastasis curve respectively. The group was divided according to the “Maximize Risk Groups” in SurvExpress website. f Kaplan-Meier distant metastasis-free survival via KM plotter database. High and low CXCL17 expression groups were divided according to “Auto select best cutoff” in the KM plotter website. Each value is the mean ± SD of three determinations; *p < 0.05

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Animal Model, Expressing, Isolation, Enzyme-linked Immunosorbent Assay, Incubation, Generated

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 2 CXCL17 increased lung metastasis in vivo. a CXCL17 increased the lung metastasis of 4T1 cells in an orthotropic model. The total number of tumor nodule per whole lung lobes was counted and averaged among the animals of each group. b The H&E staining of tumor sections. BALB/c mice were treated with PBS or recombinant mouse CXCL17 protein by intra-tracheal administration for 14 days (1 μg/mouse, 2 times/week, n = 6 per group). 4T1 were implanted into the fat pads of mice. Tumor nodules of 4T1 in the primary site and lungs were collected after 24 days of injections. c CXCL17 increased lung metastasis in human breast MDA-MB-231. Nude mice were treated with PBS or recombinant CXCL17 protein by intra-tracheal administration for 14 days (1 μg/mouse, 2 times/week, n = 6 per group). MDA-MB-231 cells were implanted into mice by tail vein injection. The MDA- MB-231 tumor nodules in the lungs of mice were collected after 90 days of injections. d The H&E staining of tumor sections. e Knockdown of CXCL17 decreased the spontaneous metastatic ability of L4T1 cells. f The H&E staining of tumor sections. CXCL17-knockdown-L4T1 were implanted into the fat pads of mice (n = 6 per group). Tumor nodules in the lungs were collected after 24 days of injections. Representative lung tissue sections were stained with H&E and photographed at × 100 magnification. Each value is the mean ± SEM; Mann-Whitney U test was performed, *p < 0.05. T tumor

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: In Vivo, Staining, Recombinant, Injection, Knockdown, MANN-WHITNEY

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 3 CXCL17 increases the recruitment of MDSCs in metastatic lungs of mice. The effect of CXCL17 in the recruitment of CD11b+Gr-1+ MDSCs (a), CD11b+Gr-1−MDSCs (b), and CD11b+F4/80+ macrophages (c) in the lungs of mice. BALB/c mice were treated with PBS or recombinant mouse CXCL17 protein by intra-tracheal administration for 14 days (1 μg/mouse, 2 times/week, n = 6 per group). Various immune cells were isolated from the lungs of mice by antibody conjugated magnetic beads. Each value is the mean ± SEM; *p < 0.05. CXCL17 increased the migration (d) and transendothelial migration (e) of CD11b+Gr-1+ MDSCs in vitro. GPR35 inhibitor decreased the migration (f) and transendothelial migration (g) of CD11b+Gr-1+ MDSCs induced by CXCL17. CD11b+Gr-1+ MDSCs were isolated from the lungs of normal mice (n = 3). PKH26-labeled CD11b+Gr-1+ MDSCs cells were seeded onto inserts (1 × 105 cells in 3-μm pore insert for migration analysis). For transendothelial migration analysis, C166 cells were seeded in 3-μm pore collagen-coated inserts for confluent monolayer, and PKH26-labeled CD11b+Gr-1+ MDSCs cells (1 × 105/insert) were seeded onto C166 confluent monolayer inserts, and the migration of cancer cells was assessed by fluorescence microscope. CXCL17 (1 ng/ml) were added in bottom well as chemoattractant. For blocking experiment, GPR35 inhibitor (CID2745687, 2 μM) was added in the inserts. Results are representative of at least three independent experiments, and each value is the mean ± SD of three determinations. *Significant difference between the two test groups (p < 0.05)

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Recombinant, Isolation, Magnetic Beads, Migration, In Vitro, Labeling, Fluorescence, Microscopy, Blocking Assay

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 4 CXCL17 increases angiogenesis in lung metastatic niche by recruiting CD11b+Gr-1+ MDSCs. a CXCL17 increased CD31+ cells in the lungs of mice. Digital images of tissues were captured and analyzed with ImageJ software to calculate the percentage of positive cells (high positive + positive + low positive cells). b Conditioned medium (CM) (50%) of CD11b+Gr-1+ MDSCs isolated from the lungs of CXCL17-treated mice (n = 5) increased tube formation of C166 cells. The effect of CXCL17 in the PDGF-AA (c), PDGF-BB (d), VEGF-A (e), and EGF basic (f) secretions of CD11b+Gr-1+ MDSCs in vivo. BALB/c mice were treated with PBS or recombinant mouse CXCL17 protein by intra-tracheal administration for 14 days (1 μg/mouse, 2 times/ week, n = 6 per group). The lungs of these mice were harvested and constrained by CD31 antibody and H&E. Alternatively, CD11b+Gr-1+ MDSCs were isolated from lungs of PBS or CXCL17 treated mice (n = 6 per group) by antibody conjugated magnetic beads, and CM was collected after culturing for 24 h. The expression of various angiogenic factors was assessed by Luminex Assays. g CXCL17 increased the expression of PDGF-BB in CD11b+Gr- 1+ MDSCs isolated from the lungs of normal mice. CD11b+Gr-1+ MDSCs were isolated from the lungs of normal mice (n = 5) by antibody conjugated magnetic beads and treated with rmCXCL17 (10 ng/ml) for 24 h. The expression of PDGF-BB was assessed by Luminex Assays. h Inhibition of PDGFR-β by specific inhibitor (DMPQ-2HCl, 5 μM) prevents CD11b+Gr-1+ MDSC-mediated C166 tube formation. Results are representative of at least three independent experiments in vitro studies, and each value is the mean ± SD of three determinations. *Significant difference between the two test groups (p < 0.05)

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Software, Isolation, In Vivo, Recombinant, Magnetic Beads, Expressing, Luminex, Inhibition, In Vitro

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 5 CD11b+Gr-1+ myeloid cells in lungs metastatic niche promote cancer cell colonization. a CXCL17 increased cancer cell extravasation into the lungs of mice. Athymic nude mice were treated with recombinant CXCL17 protein (1 μg/mouse, 2 times/week, n = 6 per group) for 14 days; MDA-MB-231-RFP-Luc cells were injected into mice by tail vein. The lungs of these mice were harvested after 48-h injection, then examined by a confocal microscope. b Scheme of CD11b+Gr-1+ depletion in the animal model. Depletion of CD11b+Gr-1+ cells decreased CXCL17-mediated cancer extravasation (c) and tumor nodules formation (d) in the lungs of mice. e The H&E staining of tumor sections of lungs. For MDSC depletion studies, mice (n = 6 per group) were treated with isotype or anti-Gr-1 antibodies (Bio X Cell) at 100 μg/mouse intraperitoneal injections every 4th day, and 4T1 cells were injected via tail vein into the mice (n = 6 per group). The control group received intraperitoneal injection of purified rat immunoglobulins. PKH26-labeled 4T1 cells were injected into mice by tail vein for indicated times (24 days for lung metastasis and 48 h for extravasation). The lungs of these mice were harvested and examined by a confocal microscope. Each value is the mean ± SEM; *p < 0.05. White arrows indicate cancer cells

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Recombinant, Injection, Microscopy, Animal Model, Staining, Control, Purification, Labeling

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 6 CD11b+Gr-1+ MDSCs increased breast cancer extravasation and survival via PDGF-BB. CM of CD11b+Gr-1+ MDSC isolated from the lungs of CXCL17-treated or 4T1-bearing mice (n = 5) increased transendothelial migration (a) and colony formation (b) of 4T1 cells. rmPDGF enhanced 4T1 cell transendothelial migration (c) and colony formation (d). Blockade of PDGFR-β prevented transendothelial migration (e) and colony formation (f) of 4T1 cells induced by CM of CD11b+Gr-1+ MDSCs. CD11b+Gr-1+ MDSC isolation and the collection of their CMs have been described in the legend of Fig. 2. C166 cells were seeded 8-μm pore collagen-coated inserts for confluent monolayer, and PKH26-labeled 4T1 cells (1 × 105/insert) were seeded onto C166 confluent monolayer inserts, and the CM of CD11b+Gr-1+ MDSCs (50%) or rmPDGF-BB protein (20 ng/ml) were placed in the bottom well as chemoattractant. The migration of cancer cells was assessed by a fluorescence microscope. For colony formation analysis, 4T1 cells were treated with different CMs (50%) or PDGF-BB (20 ng/ml), and the colonies counted after staining. g PDGFR inhibitor imatinib decreased lung metastasis in mice (n = 6 per group). h H&E staining of lung sections. Representative lung tissue sections were stained with H&E and photographed at × 100 magnification. Results are representative of at least three independent experiments and each value is the mean ± SD of three determinations. *Significant difference between the two test groups (p < 0.05)

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Isolation, Migration, Labeling, Fluorescence, Microscopy, Staining

Journal: Breast cancer research : BCR

Article Title: CXCL17-derived CD11b + Gr-1 + myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB.

doi: 10.1186/s13058-019-1114-3

Figure Lengend Snippet: Fig. 7 A novel mechanism underlying the contribution of primary cancer to lung metastatic niche formation in breast cancer. Primary cancer- secreted CXCL17 increases the accumulation of CD11b+Gr-1+ MDSCs in the lungs, which produce PDGF-BB, resulting in enhanced angiogenesis in the lung tissue before cancer cells’ arrival. In addition, CXCL17 also drives CD11b+Gr-1+ MDSCs to exhibit supportive activity for cancer extravasation and survival by PDGF-BB production under cancer cell arrival

Article Snippet: CXCL17 levels were assessed by human or mouse CXCL17 ELISA kits (Cusabio Biotech, Wuhan, China).

Techniques: Activity Assay